FDA Approves Descovy For Use As PrEP Drug
Featured

FDA Approves Descovy For Use As PrEP Drug

The U.S. Food and Drug Administration recently approved the drug Descovy for use in at-risk teenagers and adults for HIV-1 pre-exposure prophylaxis in the hopes of decreasing the chance of becoming infected with HIV-1 infection through sexual contact.

Read story
STIs Are Not The Only Reason Your Pubic Region Itches
STDs
STIs Are Not The Only Reason Your Pubic Region Itches
When the body itches, no matter where that itch occurs, it can cause serious discomfort. However,…
Clinical Chlamydia Vaccine Trial Looks Very Promising
Chlamydia
Clinical Chlamydia Vaccine Trial Looks Very Promising
A phase one study involving 35 women have revealed researchers have developed a safe and effective…
Education Is The Best Way Parents Can Protect Their Children
STDs
Education Is The Best Way Parents Can Protect Their Children
When children become adolescents, their bodies are changing, and they become curious about what’s…
Animal Activists’ Attempts May Hinder HIV/AIDS Eradication
HIV
Animal Activists’ Attempts May Hinder HIV/AIDS Eradication
It may not be much longer before AIDS is a disease of the past. Johnson & Johnson announced its…
HIV/AIDS See Improvement But Vaccine May Still Be A Ways Off
HIV
HIV/AIDS See Improvement But Vaccine May Still Be A Ways Off
Although there has been some huge improvements in the area of HIV/AIDS treatment and prevention in…
Ontario Adds Promising New HIV Treatment To Drug Benefit Program
HIV
Ontario Adds Promising New HIV Treatment To Drug Benefit Program
Ontario has opened up avenues to a new HIV treatment as the rates of HIV diagnosis continues to…
Study Finds Repeated Semen Exposure Could Lower HIV Infection Risk
HIV
Study Finds Repeated Semen Exposure Could Lower HIV Infection Risk
Women who are repeatedly exposed to semen have a decrease chance of becoming infected with HIV, as…
Researchers Come Up With Software To Identify Patients At Risk For HIV Infection
HIV
Researchers Come Up With Software To Identify Patients At Risk For HIV Infection
A few years back, Harvard and Kaiser Permanente Northern California researchers thought up of a…
Gilead Sciences Works To Offer Pricy PrEP Pill; Patient Advocacy Groups Are Not Happy
HIV
Gilead Sciences Works To Offer Pricy PrEP Pill; Patient Advocacy Groups Are Not Happy
Gilead Sciences is working toward offering a new expensive pill that can prevent people from…